Aurinia Pharmaceuticals Inc. (AUPH) Capital expenditures 2018–2025
Aurinia Pharmaceuticals Inc. (AUPH) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$252,000FY2025 · since FY2018: $74,000 → $252,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $252,000 | -10.3% |
| FY2024 | $281,000 | -60.9% |
| FY2023 | $718,000 | +145.9% |
| FY2022 | $292,000 | -3.6% |
| FY2021 | $303,000 | -94.7% |
| FY2020 | $5.7M | +6568.2% |
| FY2019 | $85,000 | +14.9% |
| FY2018 | $74,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice